BrightFlixx Launches $35M Cash Tender for Cavitation at ~$0.105/Share
CVAT sits 58% above its 52-week low of $0.022 on elevated volume (3.1× avg).
Summary
BrightFlixx Finance formally opened its all-cash tender for all Cavitation shares on October 20, offering a net $35 million pool minus company liabilities, divided by shares outstanding on the December 24 record date. Using the company's October 16 figures — about $738,000 of liabilities and 332.8 million shares — the initial estimated price is roughly $0.105 per share, versus a $0.0341 last trade. That is a wide premium and the offer is the whole thesis here: the FY2026 10-K showed just $3,000 of revenue, a $1.4 million net loss and a going concern warning. Closing is gated on 90% minimum tender, the concurrent $7 million Alchemy Beverages offer (initial ~$0.368 per share) also hitting 90%, no material adverse effect, and CFIUS clearance. The offer runs to January 26, 2027, then extends at least 30 business days after the final price is set. Watch the record date and final price announcement around December 24 — that is when the actual per-share consideration becomes binding.
At the time of this announcement, CVAT was trading at $0.03 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $11M. The 52-week trading range was $0.02 to $0.11. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.